{"id":10086,"date":"2026-03-31T09:45:45","date_gmt":"2026-03-31T14:45:45","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?page_id=10086"},"modified":"2026-04-01T08:43:50","modified_gmt":"2026-04-01T13:43:50","slug":"paul-hallen","status":"publish","type":"page","link":"https:\/\/nanostherapeutics.com\/ja\/who-we-are\/paul-hallen\/","title":{"rendered":"\u30dd\u30fc\u30eb\u30fb\u30cf\u30ec\u30f3"},"content":{"rendered":"
\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t
\r\n\r\n\t\t\t\t\r\n\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t
\r\n\r\n\t\t\t\t\r\n\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\u79c1\u305f\u3061\u306b\u3064\u3044\u3066<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\u7d4c\u55b6\u5e79\u90e8\u30c1\u30fc\u30e0<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t
\r\n\r\n\t\t\t\t\r\n\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t
\r\n\r\n\t\t\t\t\r\n\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\u79c1\u305f\u3061\u306b\u3064\u3044\u3066<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\u7d4c\u55b6\u5e79\u90e8\u30c1\u30fc\u30e0<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t
\r\n\r\n\t\t\t\t\r\n\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t
\r\n\r\n\t\t\t\t\r\n\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\u30dd\u30fc\u30eb\u30fb\u30cf\u30ec\u30f3<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\u6700\u9ad8\u57f7\u884c\u8cac\u4efb\u8005<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t<\/path><\/svg>\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\u201c\u300c\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u5149\u907a\u4f1d\u5b66\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u91cd\u5ea6\u306e\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u6a5f\u80fd\u7684\u306a\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u53ef\u80fd\u6027\u3092\u79d8\u3081\u305f\u3001\u6839\u672c\u7684\u306b\u5dee\u5225\u5316\u3055\u308c\u305f\u30a2\u30d7\u30ed\u30fc\u30c1\u3067\u3059\u3002MCO-010\u306e\u627f\u8a8d\u53d6\u5f97\u306b\u5411\u3051\u3066\u30c1\u30fc\u30e0\u3068\u5354\u529b\u3057\u3001\u5f53\u793e\u306e\u6b21\u306e\u6210\u9577\u6bb5\u968e\u306b\u5411\u3051\u305f\u4e8b\u696d\u904b\u55b6\u304a\u3088\u3073\u5546\u696d\u9762\u3067\u306e\u6e96\u5099\u3092\u652f\u63f4\u3057\u3066\u3044\u304f\u3053\u3068\u3092\u697d\u3057\u307f\u306b\u3057\u3066\u3044\u307e\u3059\u3002\u300d\u201d<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t\t
\r\n\r\n\t\t\t\t\r\n\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\u30dd\u30fc\u30eb\u30fb\u30cf\u30ec\u30f3<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\u6700\u9ad8\u57f7\u884c\u8cac\u4efb\u8005<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t<\/path><\/svg>\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u30dd\u30fc\u30eb\u30fb\u30cf\u30ec\u30f3\u306f\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306e\u6700\u9ad8\u57f7\u884c\u8cac\u4efb\u8005\uff08COO\uff09\u3092\u52d9\u3081\u3066\u3044\u307e\u3059\u3002\u5f7c\u306f\u773c\u79d1\u533b\u7642\u6280\u8853\u3068\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u5206\u91ce\u306737\u5e74\u306e\u7d4c\u9a13\u3092\u6301\u3061\u3001\u7814\u7a76\u958b\u767a\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u30de\u30fc\u30b1\u30c6\u30a3\u30f3\u30b0\u3001\u88fd\u9020\u3001\u54c1\u8cea\u7ba1\u7406\u3001\u55b6\u696d\u6d3b\u52d5\u306a\u3069\u3001\u5e45\u5e83\u3044\u5206\u91ce\u3067\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u3092\u767a\u63ee\u3057\u3066\u304d\u307e\u3057\u305f\u3002.<\/p>

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u6700\u9ad8\u57f7\u884c\u8cac\u4efb\u8005\uff08COO\uff09\u3068\u3057\u3066\u3001\u30dd\u30fc\u30eb\u306f\u540c\u793e\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u4e8b\u696d\u3092\u7d71\u62ec\u3057\u3001\u5546\u696d\u5316\u306b\u5411\u3051\u305f\u6e96\u5099\u3001\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u3001\u90e8\u9580\u6a2a\u65ad\u7684\u306a\u696d\u52d9\u9042\u884c\u306a\u3069\u3092\u62c5\u5f53\u3057\u3001\u4e16\u754c\u4e2d\u306e\u7db2\u819c\u5909\u6027\u75be\u60a3\u60a3\u8005\u306e\u305f\u3081\u306e\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u3092\u652f\u63f4\u3057\u3066\u3044\u307e\u3059\u3002.<\/p>

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306b\u5165\u793e\u3059\u308b\u4ee5\u524d\u3001\u30dd\u30fc\u30eb\u306f\u30a2\u30eb\u30b3\u30f3\u3067\u8907\u6570\u306e\u5f79\u8077\u3092\u6b74\u4efb\u3057\u3001\u76f4\u8fd1\u3067\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u7db2\u819c\u30fb\u7dd1\u5185\u969c\u30d5\u30e9\u30f3\u30c1\u30e3\u30a4\u30ba\u62c5\u5f53\u526f\u793e\u9577\u3092\u52d9\u3081\u3066\u3044\u307e\u3057\u305f\u3002\u3053\u306e\u5f79\u8077\u306b\u304a\u3044\u3066\u3001\u5f7c\u306f\u9769\u65b0\u7684\u306a\u5916\u79d1\u7684\u30fb\u6cbb\u7642\u7684\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u958b\u767a\u3068\u5546\u696d\u5316\u3092\u4e3b\u5c0e\u3057\u30012026\u5e74BIG\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30a2\u30ef\u30fc\u30c9\u306e\u300c\u7dcf\u5408\u512a\u52dd\u300d\u306b\u8f1d\u3044\u305fUNITY\u5916\u79d1\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u306f\u3058\u3081\u3068\u3059\u308b\u6570\u3005\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u958b\u767a\u3068\u5546\u696d\u5316\u3092\u63a8\u9032\u3059\u308b\u3068\u3068\u3082\u306b\u3001\u7db2\u819c\u624b\u8853\u306b\u304a\u3051\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u6a19\u6e96\u6cbb\u7642\u306e\u5411\u4e0a\u306b\u8ca2\u732e\u3057\u307e\u3057\u305f\u3002.<\/p>

\u30dd\u30fc\u30eb\u306f\u30ad\u30e3\u30ea\u30a2\u306e\u521d\u671f\u306b\u3001\u30e6\u30cb\u30b7\u30b9\u3067\u88fd\u9020\u30a8\u30f3\u30b8\u30cb\u30a2\u30ea\u30f3\u30b0\u3068\u54c1\u8cea\u30a8\u30f3\u30b8\u30cb\u30a2\u30ea\u30f3\u30b0\u306e\u4e21\u65b9\u306e\u8077\u52d9\u3092\u6b74\u4efb\u3057\u305f\u3002\u307e\u305f\u3001\u30b8\u30fc\u30f3\u30fb\u30c7\u30fb\u30d5\u30a2\u30f3\u3068\u5171\u306b\u3001\u30b8\u30e7\u30f3\u30ba\u30fb\u30db\u30d7\u30ad\u30f3\u30b9\u5927\u5b66\u3092\u62e0\u70b9\u3068\u3059\u308b\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u4f01\u696d\u3001\u30ec\u30c6\u30a3\u30ca\u30fb\u30e9\u30dc\u3092\u5171\u540c\u8a2d\u7acb\u3057\u3001\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u75c7\uff08AMD\uff09\u306e\u6e7f\u6027\u578b\u6cbb\u7642\u306e\u305f\u3081\u306e\u30d9\u30fc\u30bf\u7dda\u653e\u5c04\u7dda\u7642\u6cd5\u306b\u95a2\u3059\u308b\u7279\u8a31\u3092\u53d6\u5f97\u3057\u305f\u3002\u3053\u306e\u7814\u7a76\u304c\u6700\u7d42\u7684\u306b\u30cd\u30aa\u30d3\u30b9\u30bf\u306e\u8a2d\u7acb\u306b\u3064\u306a\u304c\u3063\u305f\u3002.<\/p>

\u30dd\u30fc\u30eb\u306f\u30a2\u30eb\u30b3\u30f3\u5728\u7c4d\u671f\u9593\u4e2d\u3001\u7db2\u819c\u75be\u60a3\u6cbb\u7642\u85ac\u3001\u5916\u79d1\u7528\u533b\u85ac\u54c1\u8ca9\u58f2\u3001\u7814\u7a76\u958b\u767a\u3001\u5916\u90e8\u4f01\u696d\u8cb7\u53ce\u306a\u3069\u3001\u5e45\u5e83\u3044\u5206\u91ce\u3067\u4e0a\u7d1a\u7ba1\u7406\u8077\u3092\u52d9\u3081\u307e\u3057\u305f\u3002\u307e\u305f\u3001\u8907\u6570\u306e\u7279\u8a31\u306e\u767a\u660e\u8005\u3068\u3057\u3066\u540d\u3092\u9023\u306d\u3066\u304a\u308a\u3001\u30a2\u30eb\u30b3\u30f3\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u5206\u91ce\u306b\u304a\u3051\u308b\u529f\u7e3e\u3092\u79f0\u3048\u3089\u308c\u3001\u30a2\u30eb\u30b3\u30f3\u7279\u5225\u30d5\u30a7\u30ed\u30fc\u306b\u9078\u51fa\u3055\u308c\u307e\u3057\u305f\u3002.<\/p>

\u30dd\u30fc\u30eb\u306f\u3001\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u7acb\u5927\u5b66\u30b5\u30f3\u30eb\u30a4\u30b9\u30aa\u30d3\u30b9\u30dd\u6821\u3067\u7523\u696d\u5de5\u5b66\u306e\u7406\u5b66\u58eb\u53f7\u3001\u5357\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5927\u5b66\u3067\u30b7\u30b9\u30c6\u30e0\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u4fee\u58eb\u53f7\u3092\u53d6\u5f97\u3057\u3066\u304a\u308a\u3001\u3055\u3089\u306b\u30c6\u30ad\u30b5\u30b9\u30af\u30ea\u30b9\u30c1\u30e3\u30f3\u5927\u5b66\u3068\u30b9\u30bf\u30f3\u30d5\u30a9\u30fc\u30c9\u5927\u5b66\u3067\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u5411\u3051\u5c02\u9580\u30b3\u30fc\u30b9\u3092\u4fee\u4e86\u3057\u3066\u3044\u308b\u3002<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\u7d4c\u55b6\u9663\u306b\u623b\u308b<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Who We Are Executive Leadership Team Who We Are Executive Leadership Team Paul Hallen Chief Operating Officer \u201cNanoscope\u2019s optogenetic platform represents a fundamentally differentiated approach with the potential to restore functional vision for patients with severe retinal disease. I look forward to working with the team to help advance MCO-010 toward potential approval and to support the company\u2019s operational and commercial readiness for our next stage of growth.\u201d Paul Hallen Chief Operating Officer Paul Hallen serves as Chief Operating Officer of Nanoscope Therapeutics. He brings 37 years of experience in ophthalmic medical technology and biopharmaceuticals, with leadership roles spanning R&D, global marketing, manufacturing, quality, and commercial operations. As COO of […]<\/p>\n","protected":false},"author":1,"featured_media":10084,"parent":6174,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-10086","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nPaul Hallen - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/who-we-are\/paul-hallen\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Paul Hallen - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/who-we-are\/paul-hallen\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-01T13:43:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_WEB_PaulHallen_Lavender.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data1\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/who-we-are\\\/paul-hallen\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/who-we-are\\\/paul-hallen\\\/\",\"name\":\"Paul Hallen - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/who-we-are\\\/paul-hallen\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/who-we-are\\\/paul-hallen\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_WEB_PaulHallen_Lavender.jpg\",\"datePublished\":\"2026-03-31T14:45:45+00:00\",\"dateModified\":\"2026-04-01T13:43:50+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/who-we-are\\\/paul-hallen\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/who-we-are\\\/paul-hallen\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/who-we-are\\\/paul-hallen\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_WEB_PaulHallen_Lavender.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_WEB_PaulHallen_Lavender.jpg\",\"width\":800,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/who-we-are\\\/paul-hallen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Who We Are\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/who-we-are\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Paul Hallen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30dd\u30fc\u30eb\u30fb\u30cf\u30ec\u30f3 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/who-we-are\/paul-hallen\/","og_locale":"ja_JP","og_type":"article","og_title":"Paul Hallen - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/who-we-are\/paul-hallen\/","og_site_name":"Nanoscope Therapeutics","article_modified_time":"2026-04-01T13:43:50+00:00","og_image":[{"width":800,"height":800,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_WEB_PaulHallen_Lavender.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@NSTherapeutics","twitter_misc":{"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/who-we-are\/paul-hallen\/","url":"https:\/\/nanostherapeutics.com\/who-we-are\/paul-hallen\/","name":"\u30dd\u30fc\u30eb\u30fb\u30cf\u30ec\u30f3 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/who-we-are\/paul-hallen\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/who-we-are\/paul-hallen\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_WEB_PaulHallen_Lavender.jpg","datePublished":"2026-03-31T14:45:45+00:00","dateModified":"2026-04-01T13:43:50+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/who-we-are\/paul-hallen\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/who-we-are\/paul-hallen\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/who-we-are\/paul-hallen\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_WEB_PaulHallen_Lavender.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_WEB_PaulHallen_Lavender.jpg","width":800,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/who-we-are\/paul-hallen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Who We Are","item":"https:\/\/nanostherapeutics.com\/who-we-are\/"},{"@type":"ListItem","position":3,"name":"Paul Hallen"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/pages\/10086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=10086"}],"version-history":[{"count":24,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/pages\/10086\/revisions"}],"predecessor-version":[{"id":10126,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/pages\/10086\/revisions\/10126"}],"up":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/pages\/6174"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/10084"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=10086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}